Literature DB >> 17350559

Mental health case conferences in primary care: content and treatment decision making.

J Simon Bell1, Parisa Aslani, Andrew J McLachlan, Paula Whitehead, Timothy F Chen.   

Abstract

BACKGROUND: Case conferences are multidisciplinary meetings of health professionals to plan treatment for specific people with chronic and complex care needs. The value of multidisciplinary teamwork in mental health care is well recognized.
OBJECTIVE: This study aimed to explore the process of decision making in mental health case conferences involving community pharmacists and primary care physicians.
METHODS: Case conferences were conducted for 44 people receiving one or more medicines for a mental illness. Before participating in the case conferences, pharmacists conducted home visits and produced written reports that detailed Home Medicines Review findings and recommendations. The case conferences were audio taped and transcribed verbatim. A framework, based on the 3 components of decision making (derived from the Model of Shared Decision Making), was used to code statements made at the case conferences. These components were (1) information exchange, (2) deliberation, and (3) decision making.
RESULTS: Pharmacists and physicians exchanged personal and medical information. Pharmacists presented their treatment findings and recommendations, and generally a brief discussion about treatment options followed (deliberation). The responsibility for deciding which treatments to implement (decision) typically remained with the physicians.
CONCLUSIONS: The case conferences provided an opportunity for pharmacists and physicians to share information and discuss treatment options. Responsibility for deciding which treatment to implement generally remained with the primary care physicians.

Entities:  

Mesh:

Year:  2007        PMID: 17350559     DOI: 10.1016/j.sapharm.2006.05.005

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  8 in total

1.  The clinical impact of pharmacist services on mental health collaborative teams: A systematic review.

Authors:  Brandy Davis; Jingjing Qian; Surachat Ngorsuraches; Ruth Jeminiwa; Kimberly B Garza
Journal:  J Am Pharm Assoc (2003)       Date:  2020-06-27

Review 2.  New roles for pharmacists in community mental health care: a narrative review.

Authors:  Maria Rubio-Valera; Timothy F Chen; Claire L O'Reilly
Journal:  Int J Environ Res Public Health       Date:  2014-10-21       Impact factor: 3.390

3.  Nurses' and pharmacists' learning experiences from participating in interprofessional medication reviews for elderly in primary health care - a qualitative study.

Authors:  H T Bell; A G Granas; I Enmarker; R Omli; A Steinsbekk
Journal:  BMC Fam Pract       Date:  2017-02-28       Impact factor: 2.497

4.  Bridging the gap between physical and mental illness in community pharmacy (PharMIbridge): protocol for an Australian cluster randomised controlled trial.

Authors:  Amanda J Wheeler; Claire L O'Reilly; Sarira El-Den; Joshua Byrnes; Robert S Ware; Sara S McMillan
Journal:  BMJ Open       Date:  2020-07-23       Impact factor: 2.692

5.  Pharmacists' roles in supporting people living with severe and persistent mental illness: a systematic review protocol.

Authors:  Sarira El-Den; Sara S McMillan; Amanda J Wheeler; Ricki Ng; Helena Roennfeldt; Claire L O'Reilly
Journal:  BMJ Open       Date:  2020-07-13       Impact factor: 2.692

Review 6.  Current perspectives on pharmacist home visits: do we keep reinventing the wheel?

Authors:  Priti S Flanagan; Andrea Barns
Journal:  Integr Pharm Res Pract       Date:  2018-10-01

7.  The Reality of Uncertainty in Mental Health Care Settings Seeking Professional Integration: A Mixed-Methods Approach.

Authors:  Chiara Pomare; Louise A Ellis; Kate Churruca; Janet C Long; Jeffrey Braithwaite
Journal:  Int J Integr Care       Date:  2018-12-19       Impact factor: 5.120

8.  Developing interprofessional care plans in chronic care: a scoping review.

Authors:  Jerôme Jean Jacques van Dongen; Marloes Amantia van Bokhoven; Ramon Daniëls; Trudy van der Weijden; Wencke Wilhelmina Gerarda Petronella Emonts; Anna Beurskens
Journal:  BMC Fam Pract       Date:  2016-09-21       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.